Alaunos Therapeutics (TCRT) Institutional Ownership $2.81 -0.17 (-5.70%) Closing price 03:59 PM EasternExtended Trading$2.80 -0.02 (-0.53%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Alaunos Therapeutics (NASDAQ:TCRT)CurrentInstitutional OwnershipPercentage27.72%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.93M Get TCRT Insider Trade Alerts Want to know when executives and insiders are buying or selling Alaunos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCRT Institutional Buying and Selling by Quarter Alaunos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024MSD Partners L.P.101,010$325K0.2%-90.0%6.313% 5/20/2024Virtu Financial LLC15,440$28K0.0%N/A0.096% 5/2/2024Magnolia Capital Advisors LLC24,695$45K0.0%-93.8%0.154% 4/30/2024Fortis Group Advisors LLC13,999$25K0.0%N/A0.087% 2/20/2024MSD Partners L.P.15,151,516$1.07M0.1%-33.3%94.402% 2/9/2024Commerce Bank437,000$31K0.0%-4.8%2.723% 2/2/2024Magnolia Capital Advisors LLC401,507$28K0.0%-7.3%0.167% 11/4/2023Magnolia Capital Advisors LLC432,969$56K0.1%N/A0.180% 7/20/2023Allred Capital Management LLC253,000$129K0.1%+24.6%0.105% 5/12/2023CIBC Private Wealth Group LLC50,400$32K0.0%+65.8%0.021% Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/21/2023Chiron Capital Management LLC81,830$52K0.0%-22.7%0.034% 2/15/2023Allred Capital Management LLC193,000$125K0.1%+22.2%0.089% 2/14/2023Discovery Capital Management LLC CT16,185,998$10.51M1.5%+10.5%7.487% 2/13/2023 GSA Capital Partners LLP957,348$621K0.1%+57.4%0.443% 1/30/2023Welch Group LLC43,000$28K0.0%-26.7%0.020% 1/9/2023Addison Capital Co15,870$2.32M1.5%N/A0.007% 11/15/2022Laurion Capital Management LP4,220,500$7.26M0.0%-1.6%1.952% 11/15/2022Magnolia Capital Advisors LLC418,569$720K0.6%+25.1%0.194% 11/15/2022Boxer Capital LLC1,500,000$2.58M0.1%N/A0.694% 11/15/2022Caxton Associates LP311,974$537K0.1%+209.8%0.144% 11/14/2022Zacks Investment Management44,550$77K0.0%N/A0.021% 11/14/2022Tudor Investment Corp Et Al39,374$68K0.0%-88.1%0.018% 11/14/2022Cubist Systematic Strategies LLC349,867$602K0.0%+4,589.3%0.162% 11/14/2022Ergoteles LLC485,434$835K0.0%-48.2%0.225% 11/14/2022E Fund Management Co. Ltd.15,167$26K0.0%N/A0.007% 11/7/2022Virtu Financial LLC74,592$128K0.0%N/A0.035% 11/3/2022Mutual Advisors LLC22,095$38K0.0%-40.4%0.010% 11/3/2022Barclays PLC136,136$234K0.0%N/A0.063% 10/31/2022Concorde Asset Management LLC35,500$61K0.1%N/A0.016% 10/31/2022Green Square Capital Advisors LLC1,080,000$1.86M0.3%N/A0.500% 10/26/2022Belvedere Trading LLC66,493$78K0.0%N/A0.031% 10/24/2022 ACT Wealth Management LLC38,476$66K0.0%N/A0.018% 10/17/2022SevenBridge Financial Group LLC20,000$34K0.0%N/A0.009% 10/14/2022Private Advisor Group LLC119,374$206K0.0%N/A0.055% 10/13/2022Chiron Capital Management LLC116,860$201K0.1%N/A0.054% 10/13/2022Welch Group LLC58,700$101K0.0%N/A0.027% 10/11/2022Sugarloaf Wealth Management LLC79,050$136K0.0%N/A0.037% 10/4/2022 AdvisorNet Financial Inc42,329$73K0.0%N/A0.020% 8/16/2022Discovery Capital Management LLC CT14,125,079$17.52M2.3%N/A6.541% 8/15/2022Laurion Capital Management LP4,289,193$5.32M0.1%N/A1.986% BREAKING: The House just passed 3 pro-crypto bills! (Ad)Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the country are buzzing in anticipationClick here to discover my #1 Coin To Own Right Now.8/15/2022Kettle Hill Capital Management LLC344,400$427K0.1%N/A0.159% 8/12/2022Commerce Bank459,000$569K0.0%N/A0.213% 8/10/2022Synovus Financial Corp33,000$41K0.0%N/A0.015% 8/8/2022Nicolet Advisory Services LLC21,500$30K0.0%N/A0.010% 8/8/2022Oppenheimer & Co. Inc.45,500$56K0.0%N/A0.021% 8/8/2022Y Intercept Hong Kong Ltd25,079$31K0.0%N/A0.012% 8/5/2022Gamble Jones Investment Counsel61,000$76K0.0%N/A0.028% 8/5/2022Horizon Kinetics Asset Management LLC34,000$42K0.0%N/A0.016% 8/4/2022Steward Partners Investment Advisory LLC36,106$45K0.0%N/A0.017% 8/3/2022CIBC Private Wealth Group LLC41,490$51K0.0%N/A0.019% 8/3/2022Stephens Inc. AR25,162$31K0.0%N/A0.012% 8/3/2022 Janney Montgomery Scott LLC82,412$101K0.0%N/A0.038% (Data available from 1/1/2016 forward) TCRT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCRT shares? During the previous two years, the following institutional investors and hedge funds held shares of Alaunos Therapeutics shares: MSD Partners L.P. ($325K), Magnolia Capital Advisors LLC ($45K), Commerce Bank ($31K), and Virtu Financial LLC ($28K), Fortis Group Advisors LLC ($25K).Learn more on Alaunos Therapeutics' institutional investors. What percentage of Alaunos Therapeutics' stock is owned by institutional investors? 27.72% of Alaunos Therapeutics' stock is owned by institutional investors. Learn more on TCRT's institutional investor holdings. Which institutional investors have been buying Alaunos Therapeutics' stock? The following institutional investors have purchased Alaunos Therapeutics' stock in the last 24 months: Magnolia Capital Advisors LLC ($432.97K), Virtu Financial LLC ($15.44K), and Fortis Group Advisors LLC ($14.00K). Which of Alaunos Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Alaunos Therapeutics stock in the last 24 months: MSD Partners L.P. ($909.09K). How much institutional selling is happening at Alaunos Therapeutics? Institutional investors have sold a total of 909,091 shares in the last 24 months. This volume of shares sold represents approximately $2.93M in transactions. Related Companies Aspire Biopharma Major Shareholders BioLineRx Major Shareholders Lexaria Bioscience Major Shareholders Synlogic Major Shareholders Gelteq Major Shareholders Athira Pharma Major Shareholders Marker Therapeutics Major Shareholders Passage Bio Major Shareholders Lipocine Major Shareholders Hoth Therapeutics Major Shareholders This page (NASDAQ:TCRT) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
